Glial activation: a driving force for pathological pain
- PMID: 11476884
- DOI: 10.1016/s0166-2236(00)01854-3
Glial activation: a driving force for pathological pain
Abstract
Pain is classically viewed as being mediated solely by neurons, as are other sensory phenomena. The discovery that spinal cord glia (microglia and astrocytes) amplify pain requires a change in this view. These glia express characteristics in common with immune cells in that they respond to viruses and bacteria, releasing proinflammatory cytokines, which create pathological pain. These spinal cord glia also become activated by certain sensory signals arriving from the periphery. Similar to spinal infection, these signals cause release of proinflammatory cytokines, thus creating pathological pain. Taken together, these findings suggest a new, dramatically different approach to pain control, as all clinical therapies are focused exclusively on altering neuronal, rather than glial, function.
Similar articles
-
Spinal glial activation contributes to pathological pain states.Neurosci Biobehav Rev. 2008 Jul;32(5):972-83. doi: 10.1016/j.neubiorev.2008.03.009. Epub 2008 Apr 3. Neurosci Biobehav Rev. 2008. PMID: 18471878 Review.
-
Perspectives in Pain Research 2014: Neuroinflammation and glial cell activation: The cause of transition from acute to chronic pain?Scand J Pain. 2015 Jan 1;6(1):3-6. doi: 10.1016/j.sjpain.2014.10.002. Scand J Pain. 2015. PMID: 29911589
-
The role of glia in the spinal cord in neuropathic and inflammatory pain.Handb Exp Pharmacol. 2015;227:145-70. doi: 10.1007/978-3-662-46450-2_8. Handb Exp Pharmacol. 2015. PMID: 25846618 Review.
-
Spinal glia and chronic pain.Metabolism. 2010 Oct;59 Suppl 1:S21-6. doi: 10.1016/j.metabol.2010.07.011. Metabolism. 2010. PMID: 20837189 Review.
-
Glia: a novel drug discovery target for clinical pain.Nat Rev Drug Discov. 2003 Dec;2(12):973-85. doi: 10.1038/nrd1251. Nat Rev Drug Discov. 2003. PMID: 14654796 Review. No abstract available.
Cited by
-
Microglia at the Tripartite Synapse during Postnatal Development: Implications for Autism Spectrum Disorders and Schizophrenia.Cells. 2023 Dec 13;12(24):2827. doi: 10.3390/cells12242827. Cells. 2023. PMID: 38132147 Free PMC article. Review.
-
P2X4 purinoceptor signaling in chronic pain.Purinergic Signal. 2012 Sep;8(3):621-8. doi: 10.1007/s11302-012-9306-7. Epub 2012 Apr 15. Purinergic Signal. 2012. PMID: 22528681 Free PMC article. Review.
-
Targeting the overproduction of peroxynitrite for the prevention and reversal of paclitaxel-induced neuropathic pain.J Neurosci. 2012 May 2;32(18):6149-60. doi: 10.1523/JNEUROSCI.6343-11.2012. J Neurosci. 2012. PMID: 22553021 Free PMC article.
-
Different peripheral tissue injury induces differential phenotypic changes of spinal activated microglia.Clin Dev Immunol. 2013;2013:901420. doi: 10.1155/2013/901420. Epub 2013 May 29. Clin Dev Immunol. 2013. PMID: 23818916 Free PMC article.
-
The narcotic bowel syndrome: clinical features, pathophysiology, and management.Clin Gastroenterol Hepatol. 2007 Oct;5(10):1126-39; quiz 1121-2. doi: 10.1016/j.cgh.2007.06.013. Clin Gastroenterol Hepatol. 2007. PMID: 17916540 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical